Biotech · Public company · New Haven, CT, US

IRulya Therapeutics Inc.

Ticker IRLA · SEC CIK 0001662774

Track this companyFree. Adds IRulya Therapeutics Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials73 recruiting or active

Pipeline programs8From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline8

Apilimod Dimesylate CapsulePhase 2 · COVID-19 DiseaseClinicalTrials.gov · fetched Nov 12, 2026
LAM-001Phase 2 · Sarcoidosis Associated Pulmonary HypertensionClinicalTrials.gov · fetched Nov 12, 2026
LAM-001Phase 2 · Pulmonary Hypertension Due to Lung Diseases and HypoxiaClinicalTrials.gov · fetched Nov 12, 2026
LAM-002APhase 2 · Amyotrophic Lateral SclerosisClinicalTrials.gov · fetched Nov 12, 2026
AtezolizumabPhase 1 · Lymphoma, Non-Hodgkin; Leukemia, Chronic LymphocyticClinicalTrials.gov · fetched Nov 12, 2026
LAM-002APhase 1 · Lymphoma, Non-Hodgkin; Leukemia, Chronic LymphocyticClinicalTrials.gov · fetched Nov 12, 2026
Open Label LAM-003Phase 1 · OncologyClinicalTrials.gov · fetched Nov 12, 2026
RituximabPhase 1 · Lymphoma, Non-Hodgkin; Leukemia, Chronic LymphocyticClinicalTrials.gov · fetched Nov 12, 2026

LAM-001 for the Treatment of Sarcoidosis Associated Pulmonary Hypertension (SAPH)PHASE2 · NOT_YET_RECRUITING · started Dec 1, 2026ClinicalTrials.gov NCT07886554 · fetched Nov 12, 2026
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)PHASE2 · RECRUITING · started Aug 30, 2023ClinicalTrials.gov NCT05798923 · fetched Nov 12, 2026
LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.PHASE2 · RECRUITING · started Aug 17, 2023ClinicalTrials.gov NCT06018766 · fetched Nov 12, 2026
Study of Safety, Tolerability, and Biological Activity of LAM-002A in C9ORF72-Associated Amyotrophic Lateral SclerosisPHASE2 · COMPLETED · started Dec 23, 2021ClinicalTrials.gov NCT05163886 · fetched Nov 12, 2026
A Study of LAM-002A for the Prevention of Progression of COVID-19PHASE2 · COMPLETED · started Jul 15, 2020ClinicalTrials.gov NCT04446377 · fetched Nov 12, 2026
A Study of LAM-003 in Patients With Acute Myeloid LeukemiaPHASE1 · COMPLETED · started Jan 16, 2018ClinicalTrials.gov NCT03426605 · fetched Nov 12, 2026
A Phase I Dose Escalation Study of the Safety and Pharmacokinetics of LAM-002A In Patients With Non-Hodgkin's LymphomaPHASE1 · COMPLETED · started Oct 1, 2015ClinicalTrials.gov NCT02594384 · fetched Nov 12, 2026